Home

Uten tvil Forhold Eller enten hat inhibitor cancer sultet Stereotype Mål

Oxygen | Free Full-Text | Comprehension of the Relationship between  Autophagy and Reactive Oxygen Species for Superior Cancer Therapy with  Histone Deacetylase Inhibitors | HTML
Oxygen | Free Full-Text | Comprehension of the Relationship between Autophagy and Reactive Oxygen Species for Superior Cancer Therapy with Histone Deacetylase Inhibitors | HTML

Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer  Resistance Protein Transporters by Histone Deacetylase Inhibition | Drug  Metabolism & Disposition
Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition | Drug Metabolism & Disposition

The role of histone deacetylases (HDACs) in human cancer - Ropero - 2007 -  Molecular Oncology - Wiley Online Library
The role of histone deacetylases (HDACs) in human cancer - Ropero - 2007 - Molecular Oncology - Wiley Online Library

Histone deacetylase modulators provided by Mother Nature | Genes &  Nutrition | Full Text
Histone deacetylase modulators provided by Mother Nature | Genes & Nutrition | Full Text

Frontiers | Small Molecules Targeting HATs, HDACs, and BRDs in Cancer  Therapy | Oncology
Frontiers | Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy | Oncology

HAT inhibitors and activators, their target histone acetyltransferases,...  | Download Table
HAT inhibitors and activators, their target histone acetyltransferases,... | Download Table

Rational Combinations Using HDAC Inhibitors | Clinical Cancer Research
Rational Combinations Using HDAC Inhibitors | Clinical Cancer Research

Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against  Breast Cancer | Anticancer Research
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer | Anticancer Research

Cureus | Advances in Epigenetic Cancer Therapeutics
Cureus | Advances in Epigenetic Cancer Therapeutics

Targeting epigenetic regulators for cancer therapy: mechanisms and advances  in clinical trials | Signal Transduction and Targeted Therapy
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy

A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets  for Cancer Therapy | Bentham Science
A Review on Important Histone Acetyltransferase (HAT) Enzymes as Targets for Cancer Therapy | Bentham Science

Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and  invasion pathways of gastric cancer cell lines
Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines

Histone Acetyltransferases (HATs) Involved in Non-Homologous End Joining as  a Target for Radiosensitization | IntechOpen
Histone Acetyltransferases (HATs) Involved in Non-Homologous End Joining as a Target for Radiosensitization | IntechOpen

Inhibition of histone acetyltransferase GCN5 extends lifespan in both yeast  and human cell lines - Huang - 2020 - Aging Cell - Wiley Online Library
Inhibition of histone acetyltransferase GCN5 extends lifespan in both yeast and human cell lines - Huang - 2020 - Aging Cell - Wiley Online Library

CPTH2 is a Potent Histone Acetyltransferase (HAT) Inhibitor - Network of  Cancer Research
CPTH2 is a Potent Histone Acetyltransferase (HAT) Inhibitor - Network of Cancer Research

KATs in cancer: functions and therapies | Oncogene
KATs in cancer: functions and therapies | Oncogene

Frontiers | Histone Deacetylase Inhibitors as Therapeutic Interventions on  Cervical Cancer Induced by Human Papillomavirus | Cell and Developmental  Biology
Frontiers | Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus | Cell and Developmental Biology

Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer
Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer

Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems:  Consequences for Precision Medicine in Malignant Disease | Cell and  Developmental Biology
Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology

Concept of histone deacetylases in cancer: Reflections on esophageal  carcinogenesis and treatment
Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment

Small molecule inhibitors of histone acetyltransferases and deacetylases  are potential drugs for inflammatory diseases - ScienceDirect
Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases - ScienceDirect

Histone acetyltransferases: challenges in targeting bi-substrate enzymes |  Clinical Epigenetics | Full Text
Histone acetyltransferases: challenges in targeting bi-substrate enzymes | Clinical Epigenetics | Full Text

HAT inhibitors in cancer therapy - ScienceDirect
HAT inhibitors in cancer therapy - ScienceDirect

Cancers | Free Full-Text | Pharmacological Inhibition of CBP/p300 Blocks  Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27  Acetylation in Luminal Breast Cancer | HTML
Cancers | Free Full-Text | Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer | HTML

Figure 1 | Targeting epigenetics for cancer therapy | SpringerLink
Figure 1 | Targeting epigenetics for cancer therapy | SpringerLink